TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biokraft Sweden AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,014
|
2,027
|
1,971 |
Financial expenses |
7,011
|
2,779
|
1,704 |
Earnings before taxes |
-3,858
|
-1,051
|
-1,101 |
EBITDA |
38
|
-180
|
-283 |
Total assets |
75,132
|
62,206
|
46,329 |
Current assets |
1,103
|
760
|
768 |
Current liabilities |
13,002
|
5,858
|
3,356 |
Equity capital |
635
|
4,480
|
6,019 |
- share capital |
5
|
4
|
5 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
0.8%
|
7.2%
|
13.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
-191.6%
|
-51.9%
|
-55.9% |
Return on assets (ROA) |
4.2%
|
2.8%
|
1.3% |
Current ratio |
8.5%
|
13.0%
|
22.9% |
Return on equity (ROE) |
-607.6%
|
-23.5%
|
-18.3% |
Change turnover |
-19
|
215
|
-519 |
Change turnover % |
-1%
|
12%
|
-21% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.